CAR T-Cell Therapy Market Report

China CAR T-Cell Therapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 22, 2022
  • PAGES：205
  • REPORT CODE：GMM1083262
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report offers an overview of the market trends, drivers, and barriers with respect to the China CAR T-Cell Therapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China CAR T-Cell Therapy market. Detailed analysis of key players, along with key growth strategies adopted by CAR T-Cell Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • CARsgen Therapeutics (China)

    • Pfizer, Inc (US)

    • Mustang Bio (US)

    • Sorrento Therapeutics (US)

    • Novartis AG (Switzerland)

    • Juno Therapeutics (US)

    • Autolus Therapeutics PLC (UK)

    • Cellectis (France)

    • Legend Biotech (US)

    • Kite Pharma (US)

    By Type:

    • Allogeneic

    • Autologous

    By End-User:

    • Hospitals

    • Cancer Research Centers

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of CAR T-Cell Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 China CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027

    • 1.3.2 China CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027

    • 1.4.2 China CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027

    • 1.4.3 China CAR T-Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of CAR T-Cell Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of CAR T-Cell Therapy by Major Types

    • 3.4.1 Market Size and Growth Rate of Allogeneic

    • 3.4.2 Market Size and Growth Rate of Autologous

    4 Segmentation of CAR T-Cell Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of CAR T-Cell Therapy by Major End-Users

    • 4.4.1 Market Size and Growth Rate of CAR T-Cell Therapy in Hospitals

    • 4.4.2 Market Size and Growth Rate of CAR T-Cell Therapy in Cancer Research Centers

    • 4.4.3 Market Size and Growth Rate of CAR T-Cell Therapy in Others

    5 Market Analysis by Regions

    • 5.1 China CAR T-Cell Therapy Production Analysis by Regions

    • 5.2 China CAR T-Cell Therapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China CAR T-Cell Therapy Landscape Analysis

    • 6.1 North China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 6.2 North China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    7 Central China CAR T-Cell Therapy Landscape Analysis

    • 7.1 Central China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 7.2 Central China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    8 South China CAR T-Cell Therapy Landscape Analysis

    • 8.1 South China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 8.2 South China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    9 East China CAR T-Cell Therapy Landscape Analysis

    • 9.1 East China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 9.2 East China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    10 Northeast China CAR T-Cell Therapy Landscape Analysis

    • 10.1 Northeast China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 10.2 Northeast China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    11 Southwest China CAR T-Cell Therapy Landscape Analysis

    • 11.1 Southwest China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 11.2 Southwest China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    12 Northwest China CAR T-Cell Therapy Landscape Analysis

    • 12.1 Northwest China CAR T-Cell Therapy Landscape Analysis by Major Types

    • 12.2 Northwest China CAR T-Cell Therapy Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 CARsgen Therapeutics (China)

      • 13.1.1 CARsgen Therapeutics (China) Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Pfizer, Inc (US)

      • 13.2.1 Pfizer, Inc (US) Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Mustang Bio (US)

      • 13.3.1 Mustang Bio (US) Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Sorrento Therapeutics (US)

      • 13.4.1 Sorrento Therapeutics (US) Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Novartis AG (Switzerland)

      • 13.5.1 Novartis AG (Switzerland) Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Juno Therapeutics (US)

      • 13.6.1 Juno Therapeutics (US) Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Autolus Therapeutics PLC (UK)

      • 13.7.1 Autolus Therapeutics PLC (UK) Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Cellectis (France)

      • 13.8.1 Cellectis (France) Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Legend Biotech (US)

      • 13.9.1 Legend Biotech (US) Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Kite Pharma (US)

      • 13.10.1 Kite Pharma (US) Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China CAR T-Cell Therapy Market Size and Growth Rate of Allogeneic from 2016 to 2027

    • Figure China CAR T-Cell Therapy Market Size and Growth Rate of Autologous from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China CAR T-Cell Therapy Market Size and Growth Rate of Hospitals from 2016 to 2027

    • Figure China CAR T-Cell Therapy Market Size and Growth Rate of Cancer Research Centers from 2016 to 2027

    • Figure China CAR T-Cell Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China CAR T-Cell Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of CAR T-Cell Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of CAR T-Cell Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of CAR T-Cell Therapy by Different Types from 2016 to 2027

    • Table Consumption Share of CAR T-Cell Therapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Allogeneic

    • Figure Market Size and Growth Rate of Autologous

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of CAR T-Cell Therapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of CAR T-Cell Therapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Cancer Research Centers

    • Figure Market Size and Growth Rate of Others

    • Table China CAR T-Cell Therapy Production by Regions

    • Table China CAR T-Cell Therapy Production Share by Regions

    • Figure China CAR T-Cell Therapy Production Share by Regions in 2016

    • Figure China CAR T-Cell Therapy Production Share by Regions in 2021

    • Figure China CAR T-Cell Therapy Production Share by Regions in 2027

    • Table China CAR T-Cell Therapy Consumption by Regions

    • Table China CAR T-Cell Therapy Consumption Share by Regions

    • Figure China CAR T-Cell Therapy Consumption Share by Regions in 2016

    • Figure China CAR T-Cell Therapy Consumption Share by Regions in 2021

    • Figure China CAR T-Cell Therapy Consumption Share by Regions in 2027

    • Table North China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table North China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure North China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure North China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure North China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table North China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table North China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure North China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure North China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure North China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table Central China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table Central China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Central China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure Central China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure Central China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table Central China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Central China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Central China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure Central China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure Central China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table South China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table South China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure South China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure South China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure South China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table South China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table South China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure South China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure South China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure South China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table East China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table East China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure East China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure East China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure East China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table East China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table East China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure East China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure East China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure East China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table Northeast China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table Northeast China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table Northeast China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Northeast China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure Northeast China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table Southwest China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table Southwest China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table Southwest China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Southwest China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure Southwest China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table Northwest China CAR T-Cell Therapy Consumption by Types from 2016 to 2027

    • Table Northwest China CAR T-Cell Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by Types in 2016

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by Types in 2021

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by Types in 2027

    • Table Northwest China CAR T-Cell Therapy Consumption by End-Users from 2016 to 2027

    • Table Northwest China CAR T-Cell Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by End-Users in 2016

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by End-Users in 2021

    • Figure Northwest China CAR T-Cell Therapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of CARsgen Therapeutics (China)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics (China)

    • Figure Sales and Growth Rate Analysis of CARsgen Therapeutics (China)

    • Figure Revenue and Market Share Analysis of CARsgen Therapeutics (China)

    • Table Product and Service Introduction of CARsgen Therapeutics (China)

    • Table Company Profile and Development Status of Pfizer, Inc (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer, Inc (US)

    • Figure Sales and Growth Rate Analysis of Pfizer, Inc (US)

    • Figure Revenue and Market Share Analysis of Pfizer, Inc (US)

    • Table Product and Service Introduction of Pfizer, Inc (US)

    • Table Company Profile and Development Status of Mustang Bio (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mustang Bio (US)

    • Figure Sales and Growth Rate Analysis of Mustang Bio (US)

    • Figure Revenue and Market Share Analysis of Mustang Bio (US)

    • Table Product and Service Introduction of Mustang Bio (US)

    • Table Company Profile and Development Status of Sorrento Therapeutics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics (US)

    • Figure Sales and Growth Rate Analysis of Sorrento Therapeutics (US)

    • Figure Revenue and Market Share Analysis of Sorrento Therapeutics (US)

    • Table Product and Service Introduction of Sorrento Therapeutics (US)

    • Table Company Profile and Development Status of Novartis AG (Switzerland)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG (Switzerland)

    • Figure Sales and Growth Rate Analysis of Novartis AG (Switzerland)

    • Figure Revenue and Market Share Analysis of Novartis AG (Switzerland)

    • Table Product and Service Introduction of Novartis AG (Switzerland)

    • Table Company Profile and Development Status of Juno Therapeutics (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics (US)

    • Figure Sales and Growth Rate Analysis of Juno Therapeutics (US)

    • Figure Revenue and Market Share Analysis of Juno Therapeutics (US)

    • Table Product and Service Introduction of Juno Therapeutics (US)

    • Table Company Profile and Development Status of Autolus Therapeutics PLC (UK)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics PLC (UK)

    • Figure Sales and Growth Rate Analysis of Autolus Therapeutics PLC (UK)

    • Figure Revenue and Market Share Analysis of Autolus Therapeutics PLC (UK)

    • Table Product and Service Introduction of Autolus Therapeutics PLC (UK)

    • Table Company Profile and Development Status of Cellectis (France)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis (France)

    • Figure Sales and Growth Rate Analysis of Cellectis (France)

    • Figure Revenue and Market Share Analysis of Cellectis (France)

    • Table Product and Service Introduction of Cellectis (France)

    • Table Company Profile and Development Status of Legend Biotech (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Legend Biotech (US)

    • Figure Sales and Growth Rate Analysis of Legend Biotech (US)

    • Figure Revenue and Market Share Analysis of Legend Biotech (US)

    • Table Product and Service Introduction of Legend Biotech (US)

    • Table Company Profile and Development Status of Kite Pharma (US)

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma (US)

    • Figure Sales and Growth Rate Analysis of Kite Pharma (US)

    • Figure Revenue and Market Share Analysis of Kite Pharma (US)

    • Table Product and Service Introduction of Kite Pharma (US)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US